Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763535
Is BMI Outdated in TKA Patient Selection? Assessment of the Impact of Pre-tubercular Subcutaneous Tissue Thickness and the Risk of Postoperative Infection Following Total Knee ArthroplastyEast Lancashire Hospitals NHS TrustNot Yet Recruiting
NCT07763535Not Yet Recruiting
—
Is BMI Outdated in TKA Patient Selection? Assessment of the Impact of Pre-tuberc...East Lancashire Hospitals...
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762105
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye DiseaseBanu Aji DibyasaktiNot Yet RecruitingPhase 1
NCT07762105Not Yet Recruiting
Phase 1
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Pa...Banu Aji Dibyasakti
NCT07763457
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduate School of MedicineNot Yet Recruiting
NCT07763457Not Yet Recruiting
—
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduat...
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's DiseaseVoyager TherapeuticsNot Yet RecruitingPhase 1
NCT07764146Not Yet Recruiting
Phase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheim...Voyager Therapeutics
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
NCT07764237
A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy AdultsModernaTX, Inc.Not Yet RecruitingPhase 1
NCT07764237Not Yet Recruiting
Phase 1
A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (...ModernaTX, Inc.
NCT07763769
Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR)Medhub Ltd.Completed
NCT07763769Completed
—
Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional...Medhub Ltd.
NCT07763353
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart FailureChung Shan Medical UniversityNot Yet RecruitingNot Applicable
NCT07763353Not Yet Recruiting
Not Applicable
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart...Chung Shan Medical Univer...
NCT07764380
Epigenetic and Cortisol Level Reflections of Maternal Stress During PregnancyKahramanmaras Sutcu Imam UniversityRecruitingNot Applicable
NCT07764380Recruiting
Not Applicable
Epigenetic and Cortisol Level Reflections of Maternal Stress During PregnancyKahramanmaras Sutcu Imam...
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07762365
Brain Stimulation Paired With Structured Reading Instruction in Children With DyslexiaGeneral Neuro Inc.RecruitingNot Applicable
NCT07762365Recruiting
Not Applicable
Brain Stimulation Paired With Structured Reading Instruction in Children With Dy...General Neuro Inc.
NCT07762001
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MDActive Not RecruitingPhase 1
NCT07762001Active Not Recruiting
Phase 1
Phase 1 Single-blind Placebo-controlled Dose Escalation Safety Study of AD-NP1Arjun Deb, MD
NCT07762261
Impact of Generative AI on University Students' Learning Processes and Critical ThinkingAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07762261Not Yet Recruiting
Not Applicable
Impact of Generative AI on University Students' Learning Processes and Critical...Ataturk University
NCT07763080
Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After MastectomyCairo UniversityNot Yet RecruitingNot Applicable
NCT07763080Not Yet Recruiting
Not Applicable
Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase...Cairo University
NCT07762248
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical PeriodontitisMohamed Ashraf AbdeenNot Yet RecruitingPhase 2
NCT07762248Not Yet Recruiting
Phase 2
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular...Mohamed Ashraf Abdeen
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07762066
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual MenFenway Community HealthRecruitingNot Applicable
NCT07762066Recruiting
Not Applicable
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression A...Fenway Community Health
NCT07763301
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic MalignanciesWest China HospitalRecruitingPhase 1
NCT07763301Recruiting
Phase 1
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignan...West China Hospital
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Completed1 (5%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Phase 15 (25%)
Not Specified4 (20%)
Phase 32 (10%)
Phase 41 (5%)
Phase 21 (5%)